Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Amino Acids. 2010 Jul 30;40(3):819–828. doi: 10.1007/s00726-010-0699-8

Fig. 5.

Fig. 5

a Immunoblots for ANP, α-actin and calsequestrin in control non-diabetic cardiomyocytes following 24 h treatment with ANG (1 μM) or PE (10 μM) in the presence of high glucose (25 mM; +HG), glucosamine (5 mM; +GlcN) or PUGNAc (100 μM; +PUGNAc). Mean densitometric data for b ANP and c α-actin expression normalized to calsequestrin from three individual experiments. *P < 0.05 versus 5 mM glucose